NASDAQ
NeuBase Therapeutics, Inc. (NBSE) has a interest coverage ratio of -1385.55x as of Friday, May 29, 2026. This represents a 70.70% decrease compared to its 12-month average of -811.69x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.